Allurion raises $27M to commercialize gastric balloon device in the U.S. and beyond

siteadmin July 11, 2017

Elipse Balloon from Allurion Technologies
Boston-based Allurion Technologies has raised $27 million in Series C funding to commercialize its intragastric balloon device. Contributors included current investor Romulus Capital, along with Cogepa Investments and IDO Investments.
“The funding…

Source: medcitynews.com – Read more